Clinical TrialsSearch results
Number of results: 195
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Unruptured Cerebral Aneurysm Study in Japan
- Unruptured intracranial aneurysms
- Society of Japan Neurosurgical Society
- 2006-05-17
Recruiting
- Trial of lactose supplementation in CDG
- Congenital disorder of glycosylation
- Maegaki Yoshihiro
- 2021-03-04
Other
- Trial for Cerebellar Ataxia Rehabilitation
- Spinocerebellar degeneration
- Brain Research Institute, Niigata University
- 2007-09-12
Completed
- Treatment of acyclovir-resistant herpetic keratitis by amenamevir
- Epithelial herpetic keratitis
- Inoue Yoshitsugu
- 2019-04-17
Other
- To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC
- unresectable stage III NSCLC
- West Japan Oncology Group
- 2005-08-29
Other
- The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
- Essential hypertension
- JATOS Study Group
- 2008-02-15
Other
- The Japan Working Group for the Assessment That the Alpha-glucosidase-inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT
- Patients With Myocardial Infarction and IGT
- National Cardiovascular Center
- 2005-08-31
Other
- The evaluation of supportive care for hand-foot syndrome and stomatitis in patients with recurrent/ relapsed Müllerian carcinoma received chemotherapy of pegylated liposomal doxorubicin
- Recurrent/ Relapsed Müllerian carcinoma
- Japan Doxil study group
- 2009-05-18
Recruiting
- The efficacy testing of a Glu-Cer against adverse skin event
- Head and Neck cancer
- Fujiwara Kazunori
- 2020-03-16
Other
- The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
- Far advanced or recurrent gastric cancer
- Department of Surgical Oncology The University of Tokyo
- 2008-08-30